title: Adherence to dual antiplatelet therapy: can we do better?
abstract: Management strategies to ensure medication adherence for patients following percutaneous coronary intervention have not changed in recent years despite the dismal rates of non-compliance with dual antiplatelet therapy. The goal of this review is to emphasis the importance of dual antiplatelet therapy in patients following percutaneous coronary intervention, discuss the clinical and economic ramifications of premature discontinuation and strategies for improvement.
authors.affiliation: Division of Cardiology, University of Illinois at Chicago, IL, USA.
authors.forename: Srinivas
authors.initials: S
authors.lastname: Yallapragada
authors.forename: Saifullah
authors.initials: S
authors.lastname: Siddiqui
authors.forename: Ryan
authors.initials: R
authors.lastname: Gindi
authors.forename: Adhir
authors.initials: A
authors.lastname: Shroff
mesh_terms: D004359:Drug Therapy, Combination; D017048:Health Care Costs; D006801:Humans; D055118:Medication Adherence; D062645:Percutaneous Coronary Intervention / Q000379:methods*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D010975:Platelet Aggregation Inhibitors